Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT201608063051N10Phase 3Completed
Phase 3 trial of lidocaine, sponsored by Qazvin University of Medical Sciences. Primary endpoint: Change in Bispectral Index (BIS). Started Dec 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT201608063051N10.